Company logo
צילום: גלעד קוולרצ'יק
Teva expects profit boost in 2009
Israel-based pharmaceutical company foresees profit between $2.65 and $2.85 per share
Teva Pharmaceutical Industries Ltd. said Tuesday it expects higher profit in 2009 on sales increases, especially in the second half of the year.
Analysts polled by Thomson Reuters expect profit of $2.89 per share on revenue of $15.21 billion in 2009.
Teva is excluding charges for buyouts, restructuring, and financial assets. Including charges, it expects profit between $2.65 and $2.85 per share.
Shares of Israel-based Teva rose $2.05, or 4.7%, on Tuesday to $46.06 in midday trading.
